vTv Therapeutics Inc. - Class A Common Stock (VTVT)

28.80
+0.96 (3.45%)
NASDAQ · Last Trade: Oct 21st, 10:21 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Promising Upsides on these Biotech Penny Stocks
These three biotech stocks each have a consensus Buy rating. While they are down from historic highs, impressive upsides make them worth consideration.
Via MarketBeat · April 18, 2023